Loading...

UCSF Coronavirus Response: UCSF is partnering with public agencies to address the rapidly evolving outbreak and protect our communities. The UCSF COVID-19 Resources Website provides guidance and information for our patients, faculty, staff, trainees and learners.

Leonardo Iaccarino, PhD

Title(s)Postdoctoral Scholar, Neurology
SchoolSchool of Medicine
vCardDownload vCard
    Other Positions
    Title(s)UCSF Weill Institute for Neurosciences


    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Iaccarino L, Sala A, Caminiti SP, Presotto L, Perani D. In vivo MRI Structural and PET Metabolic Connectivity Study of Dopamine Pathways in Alzheimer's Disease. J Alzheimers Dis. 2020 May 04. PMID: 32390614.
      View in: PubMed
    2. Tondo G, Iaccarino L, Caminiti SP, Presotto L, Santangelo R, Iannaccone S, Magnani G, Perani D. The combined effects of microglia activation and brain glucose hypometabolism in early-onset Alzheimer's disease. Alzheimers Res Ther. 2020 Apr 30; 12(1):50. PMID: 32354345.
      View in: PubMed
    3. Mantyh WG, Spina S, Lee A, Iaccarino L, Soleimani-Meigooni D, Tsoy E, Mellinger TJ, Grant H, Vandevrede L, La Joie R, Lesman-Segev O, Gaus S, Possin KL, Grinberg LT, Miller BL, Seeley WW, Rabinovici GD. Tau Positron Emission Tomographic Findings in a Former US Football Player With Pathologically Confirmed Chronic Traumatic Encephalopathy. JAMA Neurol. 2020 Apr 01; 77(4):517-521. PMID: 31904765.
      View in: PubMed
    4. Ranasinghe KG, Cha J, Iaccarino L, Hinkley LB, Beagle AJ, Pham J, Jagust WJ, Miller BL, Rankin KP, Rabinovici GD, Vossel KA, Nagarajan SS. Neurophysiological signatures in Alzheimer's disease are distinctly associated with TAU, amyloid-ß accumulation, and cognitive decline. Sci Transl Med. 2020 Mar 11; 12(534). PMID: 32161102.
      View in: PubMed
    5. Thijssen EH, La Joie R, Wolf A, Strom A, Wang P, Iaccarino L, Bourakova V, Cobigo Y, Heuer H, Spina S, VandeVrede L, Chai X, Proctor NK, Airey DC, Shcherbinin S, Duggan Evans C, Sims JR, Zetterberg H, Blennow K, Karydas AM, Teunissen CE, Kramer JH, Grinberg LT, Seeley WW, Rosen H, Boeve BF, Miller BL, Rabinovici GD, Dage JL, Rojas JC, Boxer AL. Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration. Nat Med. 2020 Mar; 26(3):387-397. PMID: 32123386.
      View in: PubMed
    6. La Joie R, Visani AV, Baker SL, Brown JA, Bourakova V, Cha J, Chaudhary K, Edwards L, Iaccarino L, Janabi M, Lesman-Segev OH, Miller ZA, Perry DC, O'Neil JP, Pham J, Rojas JC, Rosen HJ, Seeley WW, Tsai RM, Miller BL, Jagust WJ, Rabinovici GD. Prospective longitudinal atrophy in Alzheimer's disease correlates with the intensity and topography of baseline tau-PET. Sci Transl Med. 2020 01 01; 12(524). PMID: 31894103.
      View in: PubMed
    7. Sala A, Caminiti SP, Iaccarino L, Beretta L, Iannaccone S, Magnani G, Padovani A, Ferini-Strambi L, Perani D. Vulnerability of multiple large-scale brain networks in dementia with Lewy bodies. Hum Brain Mapp. 2019 10 15; 40(15):4537-4550. PMID: 31322307.
      View in: PubMed
    8. Orit H. Lesman-Segev, Lucy Hanna, Renaud La Joie, Leonardo Iaccarino, Barry Siegel, Bruce E. Hillner, Rachel A. Whitmer, Maria C. Carrillo, Charles Apgar, Cynthia Olson, Lauren Edwards, Kiran Chaudhary, Constantine Gatsonis, Gil D. Rabinovici. PREDICTORS OF ß-AMYLOID POSITIVITY IN COGNITIVELY IMPAIRED PATIENTS: DATA FROM THE IMAGING DEMENTIA — EVIDENCE FOR AMYLOID SCANNING (IDEAS) STUDY. Alzheimer's & Dementia. 2019 Jul 1; 15(7):p21-p22.
      View in: Publisher Site
    9. Orit H. Lesman-Segev, Lucy Hanna, Renaud La Joie, Leonardo Iaccarino, Barry Siegel, Bruce E. Hillner, Rachel A. Whitmer, Maria C. Carrillo, Charles Apgar, Cynthia Olson, Lauren Edwards, Kiran Chaudhary, Constantine Gatsonis, Gil D. Rabinovici. PREDICTORS OF ß-AMYLOID POSITIVITY IN COGNITIVELY IMPAIRED PATIENTS: DATA FROM THE IMAGING DEMENTIA – EVIDENCE FOR AMYLOID SCANNING (IDEAS) STUDY. Alzheimer's & Dementia. 2019 Jul 1; 15(7):p540-p541.
      View in: Publisher Site
    10. Leonardo Iaccarino, Daniel R. Schonhaut, Renaud La Joie, Rik Ossenkoppele, Alexandre Bejanin, Lauren Edwards, Gautam Tammewar, Julie Q. Pham, Kiran Chaudhary, Mustafa Janabi, Suzanne L. Baker, Bruce L. Miller, William J. Jagust, Gil D. Rabinovici. SPATIAL DISTRIBUTION AND TOPOGRAPHICAL RELATIONSHIPS OF PATHOLOGY AND NEURODEGENERATION IN ALZHEIMER’S DISEASE. Alzheimer's & Dementia. 2019 Jul 1; 15(7):p71-p72.
      View in: Publisher Site
    11. Niklas Mattsson, Lea T. Grinberg, Magnus Jonsson, William W. Seeley, Salvatore Spina, Shorena Janelidze, Howard J. Rosen, Adam L. Boxer, Renaud La Joie, Orit H. Lesman-Segev, Leonardo Iaccarino, Gwendlyn Kollmorgen, Udo Eichenlaub, Bruce L. Miller, Oskar Hansson, Gil D. Rabinovici. CEREBROSPINAL FLUID BIOMARKERS FOR AMYLOID AND TAU USING FULLY AUTOMATED ASSAYS: ASSOCIATIONS WITH NEUROPATHOLOGY. Alzheimer's & Dementia. 2019 Jul 1; 15(7):p1521.
      View in: Publisher Site
    12. Leonardo Iaccarino, Daniel R. Schonhaut, Renaud La Joie, Rik Ossenkoppele, Alexandre Bejanin, Lauren Edwards, Gautam Tammewar, Julie Q. Pham, Kiran Chaudhary, Mustafa Janabi, Suzanne L. Baker, Bruce L. Miller, William J. Jagust, Gil D. Rabinovici. SPATIAL DISTRIBUTION AND TOPOGRAPHICAL RELATIONSHIPS OF PATHOLOGY AND NEURODEGENERATION IN ALZHEIMER’S DISEASE. Alzheimer's & Dementia. 2019 Jul 1; 15(7):p720-p721.
      View in: Publisher Site
    13. David N. Soleimani-Meigooni, Leonardo Iaccarino, Renaud La Joie, Orit H. Lesman-Segev, Viktoriya Bourakova, Amelia Strom, Lauren Edwards, Suzanne L. Baker, Mustafa Janabi, Rana Eser, Eva Larsen, Salvatore Spina, William W. Seeley, Lea T. Grinberg, William J. Jagust, Gil D. Rabinovici. [18F]FLORTAUCIPIR PET AND PATHOLOGY CORRELATIONS IN ALZHEIMER’S DISEASE, NON-ALZHEIMER’S TAUOPATHIES, AND OTHER NEURODEGENERATIVE DISEASES. Alzheimer's & Dementia. 2019 Jul 1; 15(7):p782.
      View in: Publisher Site
    14. Perani D, Iaccarino L, Lammertsma AA, Windhorst AD, Edison P, Boellaard R, Hansson O, Nordberg A, Jacobs AH. A new perspective for advanced positron emission tomography-based molecular imaging in neurodegenerative proteinopathies. Alzheimers Dement. 2019 08; 15(8):1081-1103. PMID: 31230910.
      View in: PubMed
    15. Iaccarino L, Sala A, Perani D. Predicting long-term clinical stability in amyloid-positive subjects by FDG-PET. Ann Clin Transl Neurol. 2019 Jun; 6(6):1113-1120. PMID: 31211176.
      View in: PubMed
    16. Ossenkoppele R, Iaccarino L, Schonhaut DR, Brown JA, La Joie R, O'Neil JP, Janabi M, Baker SL, Kramer JH, Gorno-Tempini ML, Miller BL, Rosen HJ, Seeley WW, Jagust WJ, Rabinovici GD. Tau covariance patterns in Alzheimer's disease patients match intrinsic connectivity networks in the healthy brain. Neuroimage Clin. 2019; 23:101848. PMID: 31077982.
      View in: PubMed
    17. Perani D, Iaccarino L, Jacobs AH. Application of advanced brain positron emission tomography-based molecular imaging for a biological framework in neurodegenerative proteinopathies. Alzheimers Dement (Amst). 2019 Dec; 11:327-332. PMID: 31080871.
      View in: PubMed
    18. Caminiti SP, Sala A, Iaccarino L, Beretta L, Pilotto A, Gianolli L, Iannaccone S, Magnani G, Padovani A, Ferini-Strambi L, Perani D. Brain glucose metabolism in Lewy body dementia: implications for diagnostic criteria. Alzheimers Res Ther. 2019 02 23; 11(1):20. PMID: 30797240.
      View in: PubMed
    19. Sala A, Iaccarino L, Fania P, Vanoli EG, Fallanca F, Pagnini C, Cerami C, Calvo A, Canosa A, Pagani M, Chiò A, Cistaro A, Perani D. Testing the diagnostic accuracy of [18F]FDG-PET in discriminating spinal- and bulbar-onset amyotrophic lateral sclerosis. Eur J Nucl Med Mol Imaging. 2019 May; 46(5):1117-1131. PMID: 30617963.
      View in: PubMed
    20. Perani D, Lalli S, Iaccarino L, Alongi P, Gambini O, Franzini A, Albanese A. Prefrontal Cortical Stimulation in Tourette Disorder: Proof-of-concept Clinical and Neuroimaging Study. Mov Disord Clin Pract. 2018 Sep-Oct; 5(5):499-505. PMID: 30515438.
      View in: PubMed
    21. Presotto L, Iaccarino L, Sala A, Vanoli EG, Muscio C, Nigri A, Bruzzone MG, Tagliavini F, Gianolli L, Perani D, Bettinardi V. Low-dose CT for the spatial normalization of PET images: A validation procedure for amyloid-PET semi-quantification. Neuroimage Clin. 2018; 20:153-160. PMID: 30094164.
      View in: PubMed
    22. Iaccarino L, Sala A, Caminiti SP, Santangelo R, Iannaccone S, Magnani G, Perani D. The brain metabolic signature of visual hallucinations in dementia with Lewy bodies. Cortex. 2018 11; 108:13-24. PMID: 30098477.
      View in: PubMed
    23. Leonardo Iaccarino, Arianna Sala, Daniela Perani. LONG-TERM CLINICAL STABILITY IN AMYLOID-POSITIVE SUBJECTS IS PREDICTED BY NEGATIVE FDG-PET SCAN. Alzheimer's & Dementia. 2018 Jul 1; 14(7):p1409.
      View in: Publisher Site
    24. Santos-Santos MA, Rabinovici GD, Iaccarino L, Ayakta N, Tammewar G, Lobach I, Henry ML, Hubbard I, Mandelli ML, Spinelli E, Miller ZA, Pressman PS, O'Neil JP, Ghosh P, Lazaris A, Meyer M, Watson C, Yoon SJ, Rosen HJ, Grinberg L, Seeley WW, Miller BL, Jagust WJ, Gorno-Tempini ML. Rates of Amyloid Imaging Positivity in Patients With Primary Progressive Aphasia. JAMA Neurol. 2018 03 01; 75(3):342-352. PMID: 29309493.
      View in: PubMed
    25. Belloli S, Zanotti L, Murtaj V, Mazzon C, Di Grigoli G, Monterisi C, Masiello V, Iaccarino L, Cappelli A, Poliani PL, Politi LS, Moresco RM. 18F-VC701-PET and MRI in the in vivo neuroinflammation assessment of a mouse model of multiple sclerosis. J Neuroinflammation. 2018 Feb 05; 15(1):33. PMID: 29402285.
      View in: PubMed
    26. Alongi P, Iaccarino L, Losa M, Del Vecchio A, Gerevini S, Plebani V, Di Muzio N, Mortini P, Gianolli L, Perani D. PET Evaluation of Late Cerebral Effect in Advanced Radiation Therapy Techniques for Cranial Base Tumors. Curr Radiopharm. 2018; 11(2):86-91. PMID: 29804540.
      View in: PubMed
    27. Iaccarino L, Presotto L, Bettinardi V, Gianolli L, Roiter I, Capellari S, Parchi P, Cortelli P, Perani D. An in vivo 11C-PK PET study of microglia activation in Fatal Familial Insomnia. Ann Clin Transl Neurol. 2018 01; 5(1):11-18. PMID: 29376088.
      View in: PubMed
    28. Iaccarino L, Sala A, Caminiti SP, Perani D. The emerging role of PET imaging in dementia. F1000Res. 2017; 6:1830. PMID: 29071066.
      View in: PubMed
    29. Iaccarino L, Tammewar G, Ayakta N, Baker SL, Bejanin A, Boxer AL, Gorno-Tempini ML, Janabi M, Kramer JH, Lazaris A, Lockhart SN, Miller BL, Miller ZA, O'Neil JP, Ossenkoppele R, Rosen HJ, Schonhaut DR, Jagust WJ, Rabinovici GD. Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's Disease. Neuroimage Clin. 2018; 17:452-464. PMID: 29159058.
      View in: PubMed
    30. Leonardo Iaccarino, Luca Presotto, Chiara Cerami, Valentino Bettinardi, Sandro Iannaccone, Giuseppe Magnani, Daniela Perani. CONCORDANCE IN SPATIAL EXTENT AND AMOUNT OF BRAIN MICROGLIA ACTIVATION WITH GLUCOSE HYPOMETABOLISM IN EARLY ONSET ALZHEIMER’S DISEASE. Alzheimer's & Dementia. 2017 Jul 1; 13(7):p766.
      View in: Publisher Site
    31. Cerami C, Iaccarino L, Perani D. Molecular Imaging of Neuroinflammation in Neurodegenerative Dementias: The Role of In Vivo PET Imaging. Int J Mol Sci. 2017 May 05; 18(5). PMID: 28475165.
      View in: PubMed
    32. Iaccarino L, Moresco RM, Presotto L, Bugiani O, Iannaccone S, Giaccone G, Tagliavini F, Perani D. An In Vivo 11C-(R)-PK11195 PET and In Vitro Pathology Study of Microglia Activation in Creutzfeldt-Jakob Disease. Mol Neurobiol. 2018 Apr; 55(4):2856-2868. PMID: 28455699.
      View in: PubMed
    33. Iaccarino L, Chiotis K, Alongi P, Almkvist O, Wall A, Cerami C, Bettinardi V, Gianolli L, Nordberg A, Perani D. A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting. J Alzheimers Dis. 2017; 59(2):603-614. PMID: 28671117.
      View in: PubMed
    34. Ballarini T, Iaccarino L, Magnani G, Ayakta N, Miller BL, Jagust WJ, Gorno-Tempini ML, Rabinovici GD, Perani D. Neuropsychiatric subsyndromes and brain metabolic network dysfunctions in early onset Alzheimer's disease. Hum Brain Mapp. 2016 12; 37(12):4234-4247. PMID: 27412866.
      View in: PubMed
    35. Daniel R. Schonhaut, Rik Ossenkoppele, Alexandre Bejanin, Leonardo Iaccarino, Suzanne L. Baker, Andreas Lazaris, Averill Cantwell, Gautam Tammewar, Nagehan Ayakta, Sam Lockhart, Michael Scholl, James P. O'Neil, Bruce Miller, William J. Jagust, Gil D. Rabinovici. TAU-PET PATTERNS OVERLAP AND EXCEED HYPOMETABOLISM IN ALZHEIMER'S DISEASE. Alzheimer's & Dementia. 2016 Jul 1; 12(7):p545-p547.
      View in: Publisher Site
    36. Daniel R. Schonhaut, Rik Ossenkoppele, Alexandre Bejanin, Leonardo Iaccarino, Suzanne L. Baker, Andreas Lazaris, Averill Cantwell, Gautam Tammewar, Nagehan Ayakta, Samuel N. Lockhart, Michael Scholl, James P. O'Neil, Bruce Miller, William J. Jagust, Gil D. Rabinovici. TAU-PET PATTERNS OVERLAP AND EXCEED HYPOMETABOLISM IN ALZHEIMER'S DISEASE. Alzheimer's & Dementia. 2016 Jul 1; 12(7):p132-p133.
      View in: Publisher Site
    37. Alexandre Bejanin, Nagehan Ayakta, Daniel R. Schonhaut, Gabe Marx, Gautam Tammewar, Yann Cobigo, Faye McKenna, Leonardo Iaccarino, Marilu Gorno-Tempini, Bruce Miller, William J. Jagust, Howard J. Rosen, Gil D. Rabinovici. LONGITUDINAL BRAIN METABOLIC CHANGES IN FRONTOTEMPORAL LOBAR DEGENERATION CONTINUUM. Alzheimer's & Dementia. 2016 Jul 1; 12(7):p189-p191.
      View in: Publisher Site
    38. Alexandre Bejanin, Nagehan Ayakta, Daniel R. Schonhaut, Gabe Marx, Gautam Tammewar, Yann Cobigo, Faye McKenna, Leonardo Iaccarino, Marilu Gorno-Tempini, Bruce Miller, William J. Jagust, Howard J. Rosen, Gil D. Rabinovici. LONGITUDINAL BRAIN METABOLIC CHANGES IN FRONTOTEMPORAL LOBAR DEGENERATION CONTINUUM. Alzheimer's & Dementia. 2016 Jul 1; 12(7):p64-p66.
      View in: Publisher Site
    39. Iaccarino L, Marelli S, Iannaccone S, Magnani G, Ferini-Strambi L, Perani D. Severe Brain Metabolic Decreases Associated with REM Sleep Behavior Disorder in Dementia with Lewy Bodies. J Alzheimers Dis. 2016 04 05; 52(3):989-97. PMID: 27060952.
      View in: PubMed
    40. Ambra FI, Iavarone A, Ronga B, Chieffi S, Carnevale G, Iaccarino L, Cimminella F, Chiavazzo A, Garofalo E. Qualitative patterns at Raven's colored progressive matrices in mild cognitive impairment and Alzheimer's disease. Aging Clin Exp Res. 2016 Jun; 28(3):561-5. PMID: 26296535.
      View in: PubMed
    41. Iaccarino L, Crespi C, Della Rosa PA, Catricalà E, Guidi L, Marcone A, Tagliavini F, Magnani G, Cappa SF, Perani D. The semantic variant of primary progressive aphasia: clinical and neuroimaging evidence in single subjects. PLoS One. 2015; 10(3):e0120197. PMID: 25756991.
      View in: PubMed
    42. Alongi P, Iaccarino L, Perani D. PET Neuroimaging: Insights on Dystonia and Tourette Syndrome and Potential Applications. Front Neurol. 2014; 5:183. PMID: 25295029.
      View in: PubMed
    43. Chieffi S, Iavarone A, Iaccarino L, La Marra M, Messina G, De Luca V, Monda M. Age-related differences in distractor interference on line bisection. Exp Brain Res. 2014 Nov; 232(11):3659-64. PMID: 25092273.
      View in: PubMed
    44. Daniela Perani, Leonardo Iaccarino, Valentino Bettinardi. The need for “objective measurements” in FDG and amyloid PET neuroimaging. Clinical and Translational Imaging. 2014 Aug 1; 2(4):331-342.
      View in: Publisher Site
    45. Perani D, Daniela P, Schillaci O, Orazio S, Padovani A, Alessandro P, Nobili FM, Mariano NF, Iaccarino L, Leonardo I, Della Rosa PA, Pasquale Anthony DR, Frisoni G, Giovanni F, Caltagirone C, Carlo C. A survey of FDG- and amyloid-PET imaging in dementia and GRADE analysis. Biomed Res Int. 2014; 2014:785039. PMID: 24772437.
      View in: PubMed
    46. Iaccarino L, Chieffi S, Iavarone A. Utilization behavior: what is known and what has to be known? Behav Neurol. 2014; 2014:297128. PMID: 24825954.
      View in: PubMed
    47. Daniela Perani, Orazio Schillaci, Alessandro Padovani, Flavio Mariano Nobili, Leonardo Iaccarino, Pasquale Anthony Della Rosa, Giovanni Frisoni, Carlo Caltagirone. Erratum to “A Survey of FDG- and Amyloid-PET Imaging in Dementia and GRADE Analysis”. BioMed Research International. 2014 Jan 1; 2014:1-1.
      View in: Publisher Site